UAB "Cembalta" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
12,380 |
6,221 |
34,293 |
32,828 |
16,496 |
16.72 |
265.17 |
209,666 |
684,365 |
811 |
893,220 |
2023 |
---|
126,102 |
126,102 |
88,018 |
83,617 |
83,617 |
63.36 |
66.31 |
293,283 |
747,100 |
1 |
1,040,382 |
2024 |
---|
197,850 |
197,850 |
152,078 |
144,474 |
144,474 |
75.35 |
73.02 |
437,752 |
299,895 |
1 |
737,646 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
197,850 €57 % *
Sales per employee (€)
197,850 €57 % *
Profit before tax (€)
152,078 €73 % *
Net Profit (€)
144,474 €73 % *
Profit per employee (€)
144,474 €73 % *
Total profitability (%)
75.35 %18.92 % *
Net profitability (%)
73.02 %10.12 % *
Equity (€)
437,752 €49 % *
Amounts Payable And Liabilities (€)
299,895 €-60 % *
Non-current Assets (€)
1 €0 % *
CurrentAssets (€)
737,646 €-29 % *